Cargando…

Modeling and Simulation in Clinical Pharmacology and Dose Finding

The breakout session 2 of the European Medicines Agency/European Federation of Pharmaceutical Industries and Associations Modeling and Simulation (M&S) workshop focused on two topics: when and how M&S should be used and would be accepted by the authorities for the dose-regimen selection; and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Staab, A, Rook, E, Maliepaard, M, Aarons, L, Benson, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600758/ https://www.ncbi.nlm.nih.gov/pubmed/23835940 http://dx.doi.org/10.1038/psp.2013.5

Ejemplares similares

Open Systems Pharmacology Community—An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical Sciences
por: Lippert, Jörg, et al.
Publicado: (2019)

Quantitative Systems Pharmacology and Empirical Models: Friends or Foes?
por: Benson, Neil
Publicado: (2019)

Environmental pharmacology—Dosing the environment: IUPHAR review 36
por: Connolly, Christopher N., et al.
Publicado: (2022)

Modeling and Simulation at the Interface of Nonclinical and Early Clinical Drug Development
por: Visser, S A G, et al.
Publicado: (2013)

Interchangeability of Generics—Experiences and Outlook Toward Pharmacokinetics Variability and Generic‐Generic Substitution
por: Yu, Yang, et al.
Publicado: (2018)

Role of pharmacometrics and systems pharmacology in facilitating efficient dose optimization in oncology
por: Jayachandran, Priya, et al.
Publicado: (2023)

Application of quantitative systems pharmacology to guide the optimal dosing of COVID‐19 vaccines
por: Giorgi, Mario, et al.
Publicado: (2021)

Evolution, the Immune System, and the Health Consequences of Socioeconomic Inequality
por: Rook, Graham A. W.
Publicado: (2022)

FDA Advisory Meeting Clinical Pharmacology Review Utilizes a Quantitative Systems Pharmacology (QSP) Model: A Watershed Moment?
por: Peterson, MC, et al.
Publicado: (2015)

Dose Finding in Oncology: What is Impeding Coming of Age?
por: Mayawala, Kapil, et al.
Publicado: (2022)

Models and Machines: How Deep Learning Will Take Clinical Pharmacology to the Next Level
por: Hutchinson, Lucy, et al.
Publicado: (2019)

Graphical Modeling Meets Systems Pharmacology
por: Lombardo, Rosario, et al.
Publicado: (2017)

The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations
por: Vaughn, Samuel E., et al.
Publicado: (2021)

Advancing Biosimilar Development Using Pharmacodynamic Biomarkers in Clinical Pharmacology Studies
por: Li, Junyi, et al.
Publicado: (2019)

The Role of Modeling and Simulation in Development and Registration of Medicinal Products: Output From the EFPIA/EMA Modeling and Simulation Workshop
por: Manolis, E, et al.
Publicado: (2013)

The potential and pitfalls of artificial intelligence in clinical pharmacology
por: Johnson, Martin, et al.
Publicado: (2023)

Approaching Sites of Action of Temozolomide for Pharmacological and Clinical Studies in Glioblastoma
por: Fresnais, Margaux, et al.
Publicado: (2021)

Open Access: A New Model for Publishing in the Pharmacological Sciences
por: Conway, M
Publicado: (2012)

A Perspective on Quantitative Systems Pharmacology Applications to Clinical Drug Development
por: Bai, Jane P. F., et al.
Publicado: (2020)

Quantitative Systems Pharmacology: A Case for Disease Models
por: Musante, CJ, et al.
Publicado: (2016)

Incorporating Placebo Response in Quantitative Systems Pharmacology Models
por: Wang, Evan B., et al.
Publicado: (2019)

The World Health Organization Prequalification Program and Clinical Pharmacology in 2030
por: Blaschke, Terrence F., et al.
Publicado: (2019)

Getting Innovative Therapies Faster to Patients at the Right Dose: Impact of Quantitative Pharmacology Towards First Registration and Expanding Therapeutic Use
por: Nayak, Satyaprakash, et al.
Publicado: (2018)

Methodologies for Quantitative Systems Pharmacology (QSP) Models: Design and Estimation
por: Ribba, B, et al.
Publicado: (2017)

Where Do PBPK Models Stand in Pharmacometrics and Systems Pharmacology?
por: Jamei, Masoud
Publicado: (2020)

Development of best practices in physiologically based pharmacokinetic modeling to support clinical pharmacology regulatory decision‐making—A workshop summary
por: Jean, Daphney, et al.
Publicado: (2021)

Model Description Language (MDL): A Standard for Modeling and Simulation
por: Smith, Mike K., et al.
Publicado: (2017)

Challenges and Opportunities for Quantitative Clinical Pharmacology in Cancer Immunotherapy: Something Old, Something New, Something Borrowed, and Something Blue
por: Stroh, M, et al.
Publicado: (2015)

Industrialization of Quantitative Systems Pharmacology
por: Topp, Brian, et al.
Publicado: (2019)

Evaluating Systems Pharmacology Models Is Different From Evaluating Standard Pharmacokinetic–Pharmacodynamic Models
por: Agoram, B
Publicado: (2014)

Recruiting the Immune System Against Disease: Lessons for Clinical and Systems Pharmacology
por: Vicini, Paolo, et al.
Publicado: (2019)

A Flexible Approach for Context‐Dependent Assessment of Quantitative Systems Pharmacology Models
por: Ramanujan, Saroja, et al.
Publicado: (2019)

Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective
por: Perazzolo, Simone, et al.
Publicado: (2021)

Learn–confirm in model‐informed drug development: Assessing an immunogenicity quantitative systems pharmacology platform
por: Franssen, Linnea C., et al.
Publicado: (2022)

Improving the Pipeline for Developing and Testing Pharmacological Treatments in Pregnancy
por: Chappell, Lucy C., et al.
Publicado: (2016)

Perspective on the State of Pharmacometrics and Systems Pharmacology Integration
por: Trame, Mirjam N., et al.
Publicado: (2018)

A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins
por: Kierzek, Andrzej M., et al.
Publicado: (2019)

Case-finding in clinical practice: An appropriate strategy for dementia identification?
por: Ranson, Janice M., et al.
Publicado: (2018)

Pharmacovigilance 2030: Invited Commentary for the January 2020 “Futures” Edition of Clinical Pharmacology and Therapeutics
por: Arlett, Peter, et al.
Publicado: (2019)

Potential Issues With Virtual Populations When Applied to Nonlinear Quantitative Systems Pharmacology Models
por: Duffull, Stephen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i26bnm7tqpmoorq50v6acs1isu